CAR-T cell therapies administered in an outpatient setting may be safe and feasible without intensive remote monitoring in hematologic malignancies. Receiving CAR-T cell therapies in an outpatient ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

Debiopharm ( a Swiss-based, global biopharmaceutical company, aiming to establish tomorrow’s standard-of-care to cure cancer ...

The following is a summary of “Clinical validation of a tissue-agnostic genome-wide methylome enrichment MRD assay for head ...

AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...

Recent research highlights the significance of universal germline genetic testing (GGT) in uncovering pathogenic germline ...

Approximately 90% of patients diagnosed with endometrial cancer present with complaints of irregular or postmenopausal vaginal bleeding. However, this symptom is not specific and can also occur ...

Maintain a high index of suspicion: Childhood cancers may present with symptoms that mimic more common illnesses. For ...

Study shows that dietary antigens can suppress small intestine carcinogenesis by activating T-cells through Peyer's patches.

Approval based on positive results from the IMROZ phase 3 study demonstrating Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) significantly improved progression-free ...

ALPHAMEGA Hypermarkets and the Karaiskakio Foundation have joined forces once again, promoting a common vision: a world full ...